Correction: Suppression of PKC causes oncogenic stress for triggering apoptosis in cancer cells
Metrics: PDF 414 views | ?
1Center for Drug Discovery, Northeastern University, Boston, MA, USA
2The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China
3The Institute of Clinic Sciences, Sahlgrenska Academy, Gothenburg, Sweden
*These authors contributed equally to this work
Published: February 25, 2023
Copyright: © 2023 Ganapathy et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
This article has been corrected: In Figure 3, the panel B image of MIA - MnSOD contains an accidental duplicate of the Figure 6, panel B image of MIA - GADD153. The corrected Figure 3B, produced using the original data, is shown below. The authors declare that these corrections do not change the results or conclusions of this paper.
Original article: Oncotarget. 2017; 8:30992–31002. DOI: https://doi.org/10.18632/oncotarget.16047
Figure 3: ROS regulators were activated after co-suppression of PKC α and β. (B) MnSOD expression in the cells after the treatments was analyzed by immunoblotting.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.